ISPOR Good Practices Reports are highly cited, expert consensus guidance recommendations that set international standards for HEOR and its use in healthcare decision making. Other ISPOR Reports provide guidance on important areas such as applications, HTA and policy, terms and definitions, and reviews. All ISPOR Reports are made freely available as part of the Society’s mission.
ISPOR Report Types
Most Recent
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
Clinical Outcomes
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
Economic Evaluation
Epidemiology & Public Health
Health Policy & Regulatory
-
Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes?
-
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
Health Technology Assessment
Methodological & Statistical Research
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
Patient Centered Research
-
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
Real World Data & Information Systems
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness
Specialized Treatment Areas
-
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars
-
Are We Ready For A New Approach To Comparing Coverage And Reimbursement Policies For Medical Nutrition In Key Markets
-
Being Precise About Precision Medicine: Report of the ISPOR Personalized Precision Medicine Special Interest Group
Specific Diseases & Conditions
Study Approaches
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Improving Transparency to Build Trust in Real-World Secondary Data Studies - Real-World Evidence Transparency Initiative
-
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness